BCAL Diagnostics Limited Financial Overview
BCAL Diagnostics Limited's market cap is currently AU$36.78M. The company's EPS TTM is AU$-0.009; its P/E ratio is -5.05; BCAL Diagnostics Limited is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
